Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment

Thrombosis and Haemostasis

Volumn 77, Issue 4, 1997, Pages 685-689

  Kyrle, Paul A ^a,b   Brockmeier, Johannes ^a   Weltermann, Ansgar ^a   Eichinger, Sabine ^a   Speiser, Wolfgang ^a   Lechner, Klaus ^a   Eichler, Hans Georg ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9; COUMARIN; PROTEIN C; PROTHROMBIN; THROMBIN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; HYPERCOAGULABILITY; MALE; MICROCIRCULATION; MICROVASCULATURE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKIN NECROSIS; VENOUS BLOOD;

EID: 0030891053     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656034     Document Type: Article

References (20)

1. Comp PC. Coumarin-induced skin necrosis. Drug Safety 1993; 8 (2): 128-35.
2. D'Angelo SV, Comp PC, Esmon CT, D'Angelo A. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest 1986; 77: 416-25.
3. Conway EM, Bauer KA, Barzegar S, Rosenberg RD. Suppression of nemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diseases. J Clin Invest 1987; 80: 1535-44.
4. Bauer KA. Coumarin-induced skin necrosis. Arch Dermatol 1993; 129: 766-8.
5. Bauer KA. Laboratory markers of coagulation activation. Arch Pathol Lab Med 1993; 117: 71-7.
6. Mannucci PM. Mechanisms, markers and management of coagulation activation. Br Med Bull 1994; 50: 851-70.
7. Merlini PA, Ardissino D. Laboratory measurement of thrombin activity -what every clinician scientist needs to know. Journal of Thrombosis and Thrombolysis 1995; 2: 85-92.
8. 2 generation by low-dose aspirin at the site of plug formation in man in vivo. Circulation 1987; 75: 1025-9.
9. 2 in skin-bleeding time blood and in cloned venous blood before and after administration of acetylsalicylic acid. Lancet 1983; 1: 1075-8.
10. Weiss HJ, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 71: 629-35.
11. 1alpha in humans in response to a standardized vascular injury and the influence of aspirin. Circulation 1989; 79: 29-38.
12. Gresele P, Arnout J, Deckmyn J, Huybrechts E, Pieters G, Vermylen J. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis -studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. J Clin Invest 1987; 80: 1435-45.
13. Nowak J, FitzGerald G. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J Clin Invest 1989; 83: 380-5.
14. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 440-7.
15. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MAJ. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 4533-7.
16. Miletich J, Sherman L, Broze GJ. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-6.
17. Bruhn HD, Liebisch J, Wagner D. Documentation of hypocoagulability by measurement of prothrombin fragment F1+2 when introducing oral anticoagulant therapy. Thromb Res 1992; 68: 317-9.
18. Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coag Fibrinol 1993; 4: 281-92.
19. Rao LVM, Rapaport S. Activation of factor VII bound to tissue factor: an early key step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci 1988; 85: 6687-91.
20. Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger JJ, Rosenberg RD. Detection of Factor X activation in humans. Blood 1989; 74: 2007-15.